RIGL - RIGEL PHARMACEUTICALS INC
19.91
-0.520 -2.612%
Share volume: 146,445
Last Updated: 03-13-2025
Pharmaceutical Products/Pharmaceutical Preparations:
0.01%
PREVIOUS CLOSE
CHG
CHG%
$20.43
-0.52
-0.03%
View ratios
Fiscal Date | 03-31-2023 | 06-30-2023 | 09-30-2023 | 12-31-2023 | 03-31-2024 | 06-30-2024 | 09-30-2024 | 12-31-2024 | |
---|---|---|---|---|---|---|---|---|---|
Fiscal Quarter | Q1 2023 | Q2 2023 | Q3 2023 | Q4 2023 | Q1 2024 | Q2 2024 | Q3 2024 | Q4 2024 | |
Report Date | 05-02-2023 | 08-01-2023 | 11-07-2023 | 03-05-2024 | 05-07-2024 | 08-06-2024 | 11-07-2024 | 03-04-2025 | |
Cash flow financing | 19.123 M | -373.000 K | -869.000 K | 486.000 K | -2.512 M | -752.000 K | -9.842 M | 1.465 M | |
Other financing cash flows | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | -1.004 M | -10.000 M | 0.000 | |
Cash flow | -4.074 M | 5.930 M | -1.359 M | -6.240 M | -5.013 M | 10.479 M | 15.639 M | 5.054 M | |
Net income | -13.536 M | -6.600 M | -5.692 M | 737.000 K | -8.247 M | -1.030 M | 12.421 M | 14.341 M | |
Depreciation | 357.000 K | 296.000 K | 292.000 K | 293.000 K | 400.000 K | 613.000 K | 611.000 K | 604.000 K | |
Changes in inventories | 11.077 M | 10.782 M | 6.112 M | 5.522 M | 6.579 M | 0.000 | 0.000 | 0.000 | |
Changes in receivables | 29.366 M | 20.819 M | 23.546 M | 30.550 M | 27.512 M | 0.000 | 0.000 | 0.000 | |
Investing Cashflow | 777.000 K | 2.970 M | -1.170 M | -6.874 M | 313.000 K | 10.929 M | 3.802 M | -10.914 M | |
Net Borrowings | -7.045 M | -9.750 M | -5.707 M | -3.592 M | 1.295 M | 0.000 | 0.000 | 0.000 | |
Investing Activity Other | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
Dividends Paid | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
Exchange Rate Effect | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
Capital Expenditures | 0.000 | 0.000 | 0.000 | 0.000 | -138.000 K | 0.000 | -26.000 K | -46.000 K | |
Cash Change | 58.662 M | 64.357 M | 62.351 M | 56.933 M | 49.550 M | 10.479 M | 15.639 M | 5.054 M |